Streetbeat News

Analyst Ratings

NFLX

A significant amount of unusual options activity has been observed for Netflix (NASDAQ:NFLX), with a bearish stance being taken by a majority of investors. Of the 55 strange trades detected, 45% were bullish and 54% were bearish. The trades included 8 puts and 47 calls, with a total amount of $2,613,111. Whales have been targeting a price range from $5.0 to $550.0 for Netflix over the last 3 months. The current price of NFLX is up 2.95% at $440.87. Several financial institutions have maintained their ratings on Netflix, with price targets ranging from $375 to $500.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 6:16 pm

ATVI

A significant investor has taken a bullish stance on Activision Blizzard (NASDAQ:ATVI), with 58% of the investors opening trades with bullish expectations and 41% with bearish. The trades include 9 puts, totalling $675,654, and 27 calls, totalling $2,740,608. The price target for Activision Blizzard over the last 3 months ranges from $55.0 to $90.0. The price of ATVI is up 1.11% at $84.0. Truist Securities and Benchmark have downgraded their action to Buy with a price target of $84 and $90 respectively.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 6:16 pm

META

NVDA

SGH

Needham analyst Rajvindra Gill maintains a Buy rating for SMART Global Holdings, Inc (SGH) and raises the price target from $32 to $37. SGH is divesting its Brazil segment, which is expected to boost the gross margin and free up capital for AI investment and M&A. The company's IPS segment, which accounted for 45% of sales and grew 31% Y/Y in 3Q FY23, benefits from AI, ML, and data analytics trends. SGH could deploy 50-60K NVIDIA Corp (NVDA) GPUs for AI training at scale. Rosenblatt analyst Kevin Cassidy also reiterates a Buy rating for SGH with a $35 price target.

Portfolio Pulse from Anusuya Lahiri

June 30, 2023 | 6:06 pm

HPQ

HP (NYSE:HPQ) has received mixed analyst ratings in the last quarter, with 1 somewhat bullish, 3 indifferent, and 1 somewhat bearish. The average price target is $31.2, slightly above the current price of $30.7562. The average price target has increased by 9.47% over the past month.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 6:01 pm

GBX

Greenbrier Companies (NYSE:GBX) has received mixed analyst ratings in the last quarter, with 2 somewhat bullish, 1 indifferent, and 2 somewhat bearish. The company's average 12-month price target is $37.4, which has increased by 11.31% over the past month.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 6:01 pm

VEEV

Analysts have provided various ratings for Veeva Systems (VEEV) in the last quarter, with a majority leaning towards bullish. The average price target for VEEV is $205.06, indicating an upside from the current price of $199.59. This average price target has increased by 1.31% over the past month.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 6:00 pm

MKTW

In the last quarter, Marketwise (NASDAQ:MKTW) received 6 bullish ratings from analysts, with no bearish or indifferent ratings. The company's average 12-month price target is $4.17, a 14.55% decrease from the previous average of $4.88. Analysts determine these ratings based on predictions of a company's future earnings and the risk associated with its revenue streams.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 6:00 pm

BTAI

BioXcel Therapeutics (NASDAQ:BTAI) has received mostly bullish ratings from analysts in the last quarter, with 6 bullish ratings and 1 indifferent. The average 12-month price target for the company, according to 7 analysts, is $49.86, which has increased by 28.94% over the past month.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 6:00 pm

KNX

Over the last quarter, Knight-Swift (NYSE:KNX) received 10 analyst ratings, with 4 being bullish, 3 somewhat bullish, and 3 indifferent. The average 12-month price target for the company is $65.3, a 1.63% decrease from the previous average price target of $66.38.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 6:00 pm

OPK

Opko Health's stock has been upgraded from Market Perform to Outperform by Barrington Research, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 5:57 pm